Login / Signup

Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial.

Luciana TeofiliPatrizia PapacciCarlo DaniFrancesco CresiGiulia RemaschiClaudio PellegrinoMaria BianchiGiulia AnsaldiMaria Francesca CampagnoliBarbara VaniaDomenico LeporeFabrizio Gaetano Saverio FrancoMarco FabbriRoberta Penta de Vera d' AragonaAnna MolissoEnrico BeccastriniAntonella DragonettiLorenzo OraziTina PasciutoIolanda MozzettaAntonio BaldascinoEmanuela LocatelliCaterina Giovanna ValentiniCarmen GiannantonioBrigida CarducciSabrina GabbrielliniRoberto AlbianiElena CiabattiNicola NicolottiSilvia BaroniAlessandro MazzoniFederico Genzano BessoFrancesca SerraoVelia PurcaroAlessandra CosciaRoberta PizzoloGenny RaffaeliStefania VillaIsabella MondelloAlfonso TrimarchiFlavia BecciaStefano GhirardelloGiovanni Vento
Published in: Italian journal of pediatrics (2024)
Prospectively registered at ClinicalTrials.gov on October 29, 2021. Identifier number NCT05100212.
Keyphrases
  • gestational age
  • cord blood
  • phase iii
  • phase ii
  • open label
  • birth weight
  • preterm birth
  • double blind
  • low birth weight
  • clinical trial
  • placebo controlled
  • study protocol
  • early onset
  • randomized controlled trial